X @Bloomberg

Stock Performance - Sanofi shares experienced a decline following disappointing results from a late-stage trial of its experimental dermatitis drug [1] Pharmaceutical Development - The experimental drug for dermatitis failed to meet investor expectations in a late-stage trial [1]